Should You Consider Buying the Dip in Nasdaq ETFs Right Now

Should You Consider Buying the Dip in Nasdaq ETFs Right Now

Wall Street faces uncertainty, but experts suggest buying the dip in Nasdaq ETFs could be a smart move Should You Consider Buying the Dip in Nasdaq ETFs Right Now New York: Wall Street is having a shaky start to 2025. There’s chatter that the Fed might not cut interest rates as much as some hoped.…

Zacks Highlights Biotech Stocks: Incyte, BioMarin, Exelixis, Halozyme, Blueprint

Zacks Highlights Biotech Stocks: Incyte, BioMarin, Exelixis, Halozyme, Blueprint

Zacks Equity Research reviews biotech stocks poised for growth amid economic challenges Zacks Highlights Biotech Stocks: Incyte, BioMarin, Exelixis, Halozyme, Blueprint Chicago: So, Zacks Equity Research just dropped some insights on a few biotech stocks that are looking pretty good right now. They’re talking about Incyte, BioMarin, Exelixis, Halozyme, and Blueprint Medicines. With the economy…